Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by WinterCon Sep 08, 2016 10:52am
143 Views
Post# 25217711

RE:Inventory levels...

RE:Inventory levels...
doobiebaby wrote: Happy to report that new product just hit Tweed's shop.  Bedrocan seems to be doing okay as well.  Question for the crowd.  Would you sell Mettrum now that they have virtually nothing to sell to patients?  I would sell it right now, however, I would have to pay taxes on all the gains and so I'm leaning towards just keeping it in and dealing with the short term blow if they have a couple of bad quarters due to supply shortages.  Thoughts?  Just hate the idea of paying taxes on a stock I know should do well after they get their production ramped up.  How do traders factor in the tax implications when deciding to unload a stock?  I guess if you have losses it is one thing, but I do not have losses at this point to offset the tax bill.  



You don't pay taxes until you actually withdraw the money from the account right? 
Bullboard Posts